Verdence Capital Advisors LLC Biogen Inc. Transaction History

Verdence Capital Advisors LLC

$1.08 Billion
Q1 2024

A detailed history of Verdence Capital Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 1,665 shares of BIIB stock, worth $376,956. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,665

Previous 1,674 0.54%

Holding current value

$376,956

Previous $433,000 17.09%

% of portfolio

0.03%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$212.02 - $267.71 $1,908 - $2,409	-9 Reduced 0.54%	1,665 $359,000
Q4 2023 Jan 31, 2024	BUY	$222.59 - $267.94 $6,009 - $7,234	27 Added 1.64%	1,674 $433,000
Q3 2023 Oct 25, 2023	BUY	$253.3 - $285.89 $28,369 - $32,019	112 Added 7.3%	1,647 $423,000
Q2 2023 Jul 28, 2023	SELL	$275.25 - $318.06 $17,065 - $19,719	-62 Reduced 3.88%	1,535 $437,000
Q1 2023 Apr 24, 2023	SELL	$256.56 - $292.34 $12,571 - $14,324	-49 Reduced 2.98%	1,597 $444,000

Q4 2022 Jan 20, 2023	SELL	$252.44 - $306.72 $214,826 - $261,018	-851 Reduced 34.08%	1,646 $0
Q3 2022 Nov 15, 2022	SELL	$194.69 - $268.46 $124,990 - $172,351	-642 Reduced 20.45%	2,497 $667,000
Q2 2022 Aug 08, 2022	SELL	$187.54 - $223.02 $48,947 - $58,208	-261 Reduced 7.68%	3,139 $640,000
Q1 2022 May 02, 2022	BUY	$193.77 - $244.14 $30,421 - $38,329	157 Added 4.84%	3,400 $716,000
Q4 2021 Jan 26, 2022	BUY	$223.92 - $287.77 $55,532 - $71,366	248 Added 8.28%	3,243 $778,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $6,791 - $8,857	-24 Reduced 0.79%	2,995 $848,000
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $229,215 - $367,018	-885 Reduced 22.67%	3,019 $1.05 Million
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $26,238 - $30,740	108 Added 2.85%	3,904 $1.09 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $84,344 - $126,959	-357 Reduced 8.6%	3,796 $929,000
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $284,627 - $328,638	1,075 Added 34.93%	4,153 $1.18 Million
Q2 2020 Aug 11, 2020	BUY	$258.66 - $342.55 $87,168 - $115,439	337 Added 12.29%	3,078 $824,000
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $146,792 - $186,207	546 Added 24.87%	2,741 $867,000
Q4 2019 Feb 03, 2020	SELL	$220.06 - $304.07 $18,044 - $24,933	-82 Reduced 3.6%	2,195 $651,000
Q3 2019 Mar 06, 2020	BUY	$217.44 - $243.88 $4,348 - $4,877	20 Added 0.89%	2,277 $530,000
Q2 2019 Mar 02, 2020	BUY	$219.29 - $241.72 $3,070 - $3,384	14 Added 0.62%	2,257 $528,000
Q1 2019 Mar 02, 2020	SELL	$216.71 - $338.96 $49,843 - $77,960	-230 Reduced 9.3%	2,243 $530,000
Q4 2018 Feb 25, 2020	BUY	$278.5 - $352.75 $1,392 - $1,763	5 Added 0.2%	2,473 $744,000
Q3 2018 Feb 25, 2020	SELL	$293.51 - $383.83 $32,286 - $42,221	-110 Reduced 4.27%	2,468 $872,000
Q1 2018 Jan 30, 2020	BUY	$260.13 - $367.91 $20,030 - $28,329	77 Added 3.08%	2,578 $706,000
Q4 2017 Jan 30, 2020	BUY	$307.64 - $344.58 $769,407 - $861,794	2,501	2,501 $797,000

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account

Verdence Capital Advisors LLC Biogen Inc. Transaction History